Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jian Li, Kai-Ni Shen, Wen-Rong Huang, Li-Hong Li, Huan Chen, Wen-Ming Chen, Kai-Yan Liu, Li Yu & Dao-Bin Zhou. (2014) Autologous stem cell transplant can overcome poor prognosis in patients with multiple myeloma with extramedullary plasmacytoma. Leukemia & Lymphoma 55:7, pages 1687-1690.
Read now
Read now
Xenofon Papanikolaou, Panagiotis Repousis, Tatiana Tzenou, Dimitris Maltezas, Maria Kotsopoulou, Katerina Megalakaki, Maria Angelopoulou, Elektra Dimitrakoloulou, Efstathios Koulieris, Vassiliki Bartzis, Gerasimos Pangalis, Panagiotis Panayotidis & Marie-Christine Kyrtsonis. (2013) Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Leukemia & Lymphoma 54:7, pages 1459-1464.
Read now
Read now
Benjamin Terrier, Achille Aouba, Saliou Diop, Jêrome Clerc, Viorel Vasiliu, Yves Munera & Olivier Hermine. (2006) Thyroid gland plasmacytoma with a dramatic and persistent complete response under thalidomide and dexamethasone-associated treatment. Leukemia & Lymphoma 47:7, pages 1424-1426.
Read now
Read now
Articles from other publishers (42)
Yating Li, Zhengxu Sun & Xiaoyan Qu. (2022) Advances in the treatment of extramedullary disease in multiple myeloma. Translational Oncology 22, pages 101465.
Crossref
Crossref
Burak Kuzu, Ceylan Hepokur, Mehmet Abdullah Alagoz, Serdar Burmaoglu & Oztekin Algul. (2022)
Synthesis, Biological Evaluation and
In Silico
Studies of Some 2‐Substituted Benzoxazole Derivatives as Potential Anticancer Agents to Breast Cancer
. ChemistrySelect 7:1.
Crossref
Crossref
Laura Rosiñol, Meral Beksac, Elena Zamagni, Niels W. C. J. Van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios‐Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria V. Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson & Joan Bladé. (2021) Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British Journal of Haematology 194:3, pages 496-507.
Crossref
Crossref
Mohamed Ayman El-Zahabi, Helmy Sakr, Khaled. El-Adl, Mohamed Zayed, Adel S. Abdelraheem, Sally I. Eissa, Hazem Elkady & Ibrahim H. Eissa. (2020) Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorganic Chemistry 104, pages 104218.
Crossref
Crossref
Hai-Fan Huang, Jian Xu, Ao-Shuang Xu, Xiao-Yue Wan, Lei Chen, Feng-Juan Fan, Bo Zhang, Liang Tang, Wan-Xin Chen, Xun Sun, Li-Sha Ai, Jian Hou, Chun-Yan Sun & Yu Hu. (2020) Disturbed MAPK pathway in early bilateral testicular extramedullary relapse of multiple myeloma. Leukemia Research 95, pages 106403.
Crossref
Crossref
Jianpu ChenChongjiao LiYueli TianQing XiaoMing DengHao HuBing WenYong He. (2019)
Comparison of Whole-Body DWI and
18
F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma
. American Journal of Roentgenology 213:3, pages 514-523.
Crossref
Crossref
Raquel Jiménez‐Segura, Miquel Granell, Mercè Gironella, Eugenia Abella, Antoni García‐Guiñón, Albert Oriol, Elena Cabezudo, Victoria Clapés, Joan Alfons Soler, Lourdes Escoda, Jordi López-Pardo, Carlos Fernández de Larrea, Maria Teresa Cibeira, Natalia Tovar, Ignacio Isola, Joan Bladé & Laura Rosiñol. (2019) Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma. European Journal of Haematology 102:5, pages 389-394.
Crossref
Crossref
Despina Fotiou, Meletios A. Dimopoulos & Efstathios Kastritis. (2018) How We Manage Patients with Plasmacytomas. Current Hematologic Malignancy Reports 13:3, pages 227-235.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
585
593
.
Morie A. Gertz, Laura Rosinol & Joan Bladé. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
157
175
.
Zeljko Todorovic, Milena Jovanovic, Dusan Todorovic, Anita Ivosevic, Marina Markovic, Drakce Radovanovic, Danijela Jovanovic, Vesna Cemerikic & Predrag Djurdjevic. (2017) Extramedullary Involvement of Lymph Nodes in Multiple Myeloma. Serbian Journal of Experimental and Clinical Research 18:3, pages 257-261.
Crossref
Crossref
Agnieszka Druzd-Sitek & Jan Walewski. (2017) Możliwości leczenia indukcyjnego chorych na szpiczaka plazmocytowego kwalifikujących się do chemioterapii wysokodawkowanej wspomaganej autologiczną transplantacją komórek krwiotwórczych a aktualne zalecenia Polskiej Grupy Szpiczakowej. Acta Haematologica Polonica 48:2, pages 104-111.
Crossref
Crossref
Anna Crescenzi, Ombretta Annibali, Antonella Bianchi, Anastasia Pagano, Michele Donati, Alba Grifoni & Giuseppe Avvisati. (2016) PD-1/PD-L1 expression in extra-medullary lesions of multiple myeloma. Leukemia Research 49, pages 98-101.
Crossref
Crossref
Sree Harsha Tirumani, Christopher Sakellis, Heather Jacene, Atul B. Shinagare, Nikhil C. Munshi, Nikhil H. Ramaiya & Annick D. Van den Abbeele. (2016) Role of FDG-PET/CT in Extramedullary Multiple Myeloma. Clinical Nuclear Medicine 41:1, pages e7-e13.
Crossref
Crossref
Sung-Eun Lee, Jung-Ho Kim, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hwan Shin, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Jong Wook Lee, Woo-Sung Min, Chong-Won Park & Chang-Ki Min. (2014) Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma. Annals of Hematology 94:3, pages 445-452.
Crossref
Crossref
Anup Kasi Loknath Kumar, Christopher Dakhil, Megha Teeka Satyan & Nisreen Haideri. (2014) Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report. Journal of Medical Case Reports 8:1.
Crossref
Crossref
Leo Rasche, Susanne Strifler, Johannes Duell, Andreas Rosenwald, Andreas Buck, Uwe Maeder, Hermann Einsele & Stefan Knop. (2014) The lymphoma-like polychemotherapy regimen “Dexa-BEAM” in advanced and extramedullary multiple myeloma. Annals of Hematology 93:7, pages 1207-1214.
Crossref
Crossref
Eli Muchtar, Pia Raanani, Moshe Yeshurun, Ofer Shpilberg & Hila Magen-Nativ. (2014) Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series. Acta Haematologica 132:1, pages 39-44.
Crossref
Crossref
Silvia Park, Su Jin Lee, Chul Won Jung, Jun Ho Jang, Seok Jin Kim, Won Seog Kim & Kihyun Kim. (2013) DCEP for relapsed or refractory multiple myeloma after therapy with novel agents. Annals of Hematology 93:1, pages 99-105.
Crossref
Crossref
Jan P. Pintoffl, Katja Weisel, Maximilian Schulze, Olga Maksimovic, Claus D. Claussen, Ulrich Kramer & Marius Horger. (2013) Role of Dynamic Contrast‐Enhanced Sonography for Characterization and Monitoring of Extramedullary Myeloma. Journal of Ultrasound in Medicine 32:10, pages 1777-1788.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
665
680
.
Yasunobu Sekiguchi, Syuichi Shirane, Hidenori Imai, Keiji Sugimoto, Mutsumi Wakabayashi, Tomonori Sawada, Noriko Chigira, Kunimoto Ichikawa, Norio Komatsu & Masaaki Noguchi. (2012) Response to Low-dose Bortezomib in Plasma Cell Leukemia Patients with Malignant Pleural Effusion and Ascites: A Case Report and a Review of the Literature. Internal Medicine 51:11, pages 1393-1398.
Crossref
Crossref
Shaile Philips, Christine Menias, Raghunandan Vikram, Abhijit Sunnapwar & Srinivasa R. Prasad. (2012) Abdominal Manifestations of Extraosseous Myeloma. Journal of Computer Assisted Tomography 36:2, pages 207-212.
Crossref
Crossref
Joan BladéCarlos Fernández de LarreaLaura RosiñolMaría Teresa CibeiraRaquel JiménezRay Powles. (2011) Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach. Journal of Clinical Oncology 29:28, pages 3805-3812.
Crossref
Crossref
José M. Calvo-Villas, Adrián Alegre, Carmen Calle, Miguel T. Hernández, Ricarda García-Sánchez & Gema Ramírez. (2011) Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma. European Journal of Haematology 87:3, pages 281-284.
Crossref
Crossref
M. Varettoni, A. Corso, G. Pica, S. Mangiacavalli, C. Pascutto & M. Lazzarino. (2010) Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Annals of Oncology 21:2, pages 325-330.
Crossref
Crossref
A. Siniscalchi, S. Fratoni, G. Santeusanio, G. Del Poeta, P. de Fabritiis & T. Caravita. (2009) Cutaneous involvement in multiple myeloma and bortezomib. Annals of Hematology 88:11, pages 1137-1139.
Crossref
Crossref
Enrico Balleari & Andrea Bruzzone. (2009) Unusual myeloma relapse after thalidomide therapy: The dark side of the moon?. Leukemia Research 33:9, pages 1164-1165.
Crossref
Crossref
Enrico Balleari, Roberto G. Carbone, Marco Grosso & Riccardo Ghio. (2008) A pleural effusion due to extramedullary pleural plasmacytoma: a case report. Internal and Emergency Medicine 3:3, pages 289-291.
Crossref
Crossref
Anna Candoni, Erica Simeone & Renato Fanin. (2008) Extramedullary progression of multiple myeloma under thalidomide therapy despite concomitant response of medullary disease. American Journal of Hematology 83:8, pages 680-681.
Crossref
Crossref
Jan Cerny, Oluwole Fadare, Lloyd Hutchinson & Sa A. Wang. (2008) Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma. European Journal of Haematology 81:1, pages 65-69.
Crossref
Crossref
Ashraf Badros. 2009. Myeloma Therapy. Myeloma Therapy
205
227
.
P. Raanani, O. Shpilberg & I. Ben-Bassat. (2007) Extramedullary disease and targeted therapies for hematological malignancies—is the association real?. Annals of Oncology 18:1, pages 7-12.
Crossref
Crossref
M. Teresa Cibeira, Laura Rosiñol, Laia Ramiro, Jordi Esteve, Montserrat Torrebadell & Joan Bladé. (2006) Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration. European Journal of Haematology 77:6, pages 486-492.
Crossref
Crossref
Rosinol Laura, Ma Teresa Cibeira, Carla Uriburu, Sebastian Yantorno, Olga Salamero, Joan Blade & Emili Montserrat. (2006) Bortezomib: an effective agent in extramedullary disease in multiple myeloma. European Journal of Haematology 76:5, pages 405-408.
Crossref
Crossref
D. Pantelidou, C. Tsatalas, D. Margaritis, A. G. Anastasiadis, V. Kaloutsi, P. Argyropoulou, P. Prassopoulos & G. Bourikas. (2006) Successful treatment of lymph node extramedullary plasmacytoma with bortezomib. Annals of Hematology 85:3, pages 188-190.
Crossref
Crossref
Luis Requena. (2005) Afectación cutánea específica en pacientes con mieloma múltiple. Estudio clínico-patológico, inmunohistoquímico y citogenético de 40 casos. Actas Dermo-Sifiliográficas 96:7, pages 424-440.
Crossref
Crossref
D. T. Alexandrescu, L. Koulova & P. H. Wiernik. (2005) Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature. Clinical and Experimental Dermatology 30:4, pages 391-394.
Crossref
Crossref
Auro del Giglio, Patricia Weinschenker, Ana Rita de Araújo Burgos Manhani, Ana Lucia Ippolito Carbonell & Cristina A.T.S. Mitteldorf. (2005) Hepatic Plasmacytosis as a Manifestation of Relapse in Multiple Myeloma Treated With Thalidomide. Southern Medical Journal 98:2, pages 238-240.
Crossref
Crossref
R García-Sanz, J R González-Porras, J M Hernández, M Polo-Zarzuela, A Sureda, C Barrenetxea, L Palomera, R López, C Grande-García, A Alegre, M Vargas-Pabón, O N Gutiérrez, J A Rodríguez & J F San Miguel. (2004) The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma. Leukemia 18:4, pages 856-863.
Crossref
Crossref
Meletios A. DimopoulosAthanasios AnagnostopoulosDonna Weber. (2003) Treatment of Plasma Cell Dyscrasias With Thalidomide and Its Derivatives. Journal of Clinical Oncology 21:23, pages 4444-4454.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. (2003) Thalidomide: A Step Forward in the Treatment Malignant Monoclonal Gammopathies. Clinical Lymphoma 3:4, pages 247-248.
Crossref
Crossref